Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
Frank Dowling, MD, a member of the New York Medical Association delegation, addresses the AMA House of Delegates, explaining the need for new disinformation policy. #AMA #AMAmtg #AMA175

AMA fights back against COVID-19 disinformation spread by clinicians

This new policy calls for partnerships with other professional healthcare societies to call out false information.

AMA Board of Trustees member Scott Ferguson, MD, a diagnostic radiologist, offers comment during the discussion on one of several policies to further curb gun violence. #AMA #AMAmtg #AMA175

AMA calls gun violence a healthcare crisis, adopting several new policies 

The American Medical Association voted this week to adopt several new policies related to address gun violence during the AMA’s House of Delegates 2022 annual meeting in Chicago.

Jack S. Resneck Jr., MD, was inaugurated this week as the 177th president of the American Medical Association (AMA). Resneck is a dermatologist, professor and vice-chair of the Department of Dermatology at UC San Francisco, June 14, 2022. #AMA #AMAmtg #AMA175

UCSF dermatologist inaugurated as new AMA president

Jack Resneck Jr., MD, was inaugurated this week as the 177th president of the AMA and pledged to fight injustices against both patients and physicians.

American Medical Association President Gerald Harmon, MD, explains some of the hottest topics discussed at the 2022 AMA House of Delegates meeting in Chicago. Harmon, a retired Air Force general and family practice specialist, said the top polices adopted where those that addressed gun control, physician burn out and issues regarding scope creep where non-physicians are filling roles traditionally held by doctors. #AMAmtg #AMA175 #AMA #guncontrol

VIDEO: AMA president discusses gun control, physician burnout and scope creep

American Medical Association President Gerald Harmon, MD, joined us for an exclusive chat about some of the hottest topics discussed at the 2022 AMA House of Delegates meeting.

AMA declares climate change a public health crisis

The AMA says there will be numerous major public health impacts if global temperatures continue to rise, adopting three new policies to address this ongoing trend. 

Thumbnail

Hospitals claim victory in Supreme Court Medicare payment decision

The court case stems from HHS’ 2018  final rule establishing separate reimbursement rates for hospitals that serve low-income or rural populations through the 340B program and all other hospitals.

PHOTO GALLERY from AMA House of Delegates 2022 meeting

Here are images from the American Medical Association (AMA) 2022 House of Delegates (HOD) meeting in Chicago, June 10-15. This was the first time the HOD met in two and a half years because of the COVID-19 pandemic.

Thumbnail

How one billionaire is fighting hospital monopolies

John Arnold, a Texas billionaire, has a gear to grind with big hospital monopolies.

Displaying 593 - 600 of 2773

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup